Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture Justice Kyra Harris Bolden ...

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

U.S. drugmaker Merck on Wednesday signed a deal worth up to $2 billion with Hansoh Pharmaceuticals to develop and ...

Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named ...

Merck (MRK) stock in focus as company reports mixed results in Phase 3 trials for HIV therapy islatravir in combination with ...

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024. See why I rate ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global ...

And that's why Merck could credibly become the next big weight-loss stock. Before you rush to go buy shares of Merck, ...